BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29172532)

  • 1. Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier.
    Zhao K; Han J; Zhang Y; Wei L; Yu S; Wang X; Jin Z; Wang Y
    Mol Pharm; 2018 Jan; 15(1):226-237. PubMed ID: 29172532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.
    Zhao K; Sun B; Shi C; Sun Y; Jin Z; Hu G
    J Nanobiotechnology; 2021 Aug; 19(1):240. PubMed ID: 34380522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration.
    Zhao K; Li S; Li W; Yu L; Duan X; Han J; Wang X; Jin Z
    Drug Deliv; 2017 Nov; 24(1):1574-1586. PubMed ID: 29029568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.
    Zhao K; Sun Y; Chen G; Rong G; Kang H; Jin Z; Wang X
    Carbohydr Polym; 2016 Sep; 149():28-39. PubMed ID: 27261727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-2'-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine.
    Dai C; Kang H; Yang W; Sun J; Liu C; Cheng G; Rong G; Wang X; Wang X; Jin Z; Zhao K
    Carbohydr Polym; 2015 Oct; 130():280-9. PubMed ID: 26076628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of live Newcastle disease virus encapsulated in N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan nanoparticles.
    Jin Z; Li D; Dai C; Cheng G; Wang X; Zhao K
    Carbohydr Polym; 2017 Sep; 171():267-280. PubMed ID: 28578963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
    Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S
    Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.
    Zhao K; Rong G; Guo C; Luo X; Kang H; Sun Y; Dai C; Wang X; Wang X; Jin Z; Cui S; Sun Q
    Int J Nanomedicine; 2015; 10():2895-911. PubMed ID: 25926734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvanted quaternized chitosan composite aluminum nanoparticles-based vaccine formulation promotes immune responses in chickens.
    Liu J; Guo S; Jin Z; Zhao K
    Vaccine; 2023 May; 41(18):2982-2989. PubMed ID: 37032226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.
    Zhao K; Rong G; Hao Y; Yu L; Kang H; Wang X; Wang X; Jin Z; Ren Z; Li Z
    Sci Rep; 2016 May; 6():25720. PubMed ID: 27170532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune enhancement of N-2-Hydroxypropyl trimethyl ammonium chloride chitosan/carboxymethyl chitosan nanoparticles vaccine.
    Gao Y; Gong X; Yu S; Jin Z; Ruan Q; Zhang C; Zhao K
    Int J Biol Macromol; 2022 Nov; 220():183-192. PubMed ID: 35981671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Effect of Newcastle Disease Virus DNA Vaccine with C3d as a Molecular Adjuvant.
    Zhao K; Duan X; Hao L; Wang X; Wang Y
    J Microbiol Biotechnol; 2017 Nov; 27(11):2060-2069. PubMed ID: 29061032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Zhang Y; Zhang X; Li W; Shi C; Guo C; Dai C; Chen Q; Jin Z; Zhao Y; Cui H; Wang Y
    Int J Nanomedicine; 2014; 9():389-402. PubMed ID: 24426783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.
    Zhao K; Chen G; Shi XM; Gao TT; Li W; Zhao Y; Zhang FQ; Wu J; Cui X; Wang YF
    PLoS One; 2012; 7(12):e53314. PubMed ID: 23285276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2 gene.
    Zhang W; Yin Z; Liu N; Yang T; Wang J; Bu Z; Wu D
    J Microencapsul; 2010; 27(8):693-702. PubMed ID: 21034363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine.
    Yang Y; Xing R; Liu S; Qin Y; Li K; Yu H; Li P
    Carbohydr Polym; 2020 Feb; 229():115423. PubMed ID: 31826462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Chitosan Derivatives Modified Mesoporous Silica Nanoparticles as Delivery Carrier.
    Li Q; Wang W; Hu G; Cui X; Sun D; Jin Z; Zhao K
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles.
    Zhao K; Li W; Huang T; Luo X; Chen G; Zhang Y; Guo C; Dai C; Jin Z; Zhao Y; Cui H; Wang Y
    PLoS One; 2013; 8(12):e82648. PubMed ID: 24386106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation of bivalent Newcastle disease DNA vaccine induced immune response by co-delivery of chicken IFN-γ and IL-4 genes.
    Sawant PM; Verma PC; Subudhi PK; Chaturvedi U; Singh M; Kumar R; Tiwari AK
    Vet Immunol Immunopathol; 2011 Nov; 144(1-2):36-44. PubMed ID: 21820185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
    Lin Y; Sun B; Jin Z; Zhao K
    ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.